Surmodics (SRDX) News Today $39.96 -0.05 (-0.12%) (As of 05:27 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Surmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.comDecember 17 at 2:11 AM | americanbankingnews.comStockNews.com Initiates Coverage on Surmodics (NASDAQ:SRDX)StockNews.com assumed coverage on Surmodics in a research note on Tuesday. They set a "hold" rating for the company.December 17 at 2:09 AM | marketbeat.comOddo BHF Asset Management Sas Takes Position in Surmodics, Inc. (NASDAQ:SRDX)Oddo BHF Asset Management Sas acquired a new stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 170,000 shares of the company's stock, valued at approximately $6,593,000. Oddo BHF AssetDecember 13, 2024 | marketbeat.comDisciplined Growth Investors Inc. MN Sells 303,690 Shares of Surmodics, Inc. (NASDAQ:SRDX)Disciplined Growth Investors Inc. MN cut its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 52.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 276,876 shares of the company's stock afDecember 10, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Now Covered by StockNews.comStockNews.com assumed coverage on Surmodics in a research report on Monday. They issued a "hold" rating for the company.December 9, 2024 | marketbeat.comWhy Is SurModics (SRDX) Up 4% Since Last Earnings Report?December 6, 2024 | msn.comMurchinson Ltd. Acquires Shares of 55,000 Surmodics, Inc. (NASDAQ:SRDX)Murchinson Ltd. bought a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 55,000 shares of the company's stock, valueDecember 4, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Coverage Initiated at StockNews.comStockNews.com assumed coverage on Surmodics in a research note on Sunday. They issued a "hold" rating for the company.December 1, 2024 | marketbeat.comResearch Analysts Set Expectations for Surmodics Q2 EarningsSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities research analysts at Zacks Research boosted their Q2 2025 earnings estimates for shares of Surmodics in a report issued on Monday, November 25th. Zacks Research analyst D. Dey now anticipates that the company will earn ($0.08) per share for tNovember 28, 2024 | marketbeat.comInsider Selling: Surmodics, Inc. (NASDAQ:SRDX) CFO Sells 7,009 Shares of StockNovember 28, 2024 | insidertrades.comFY2025 EPS Estimates for Surmodics Increased by AnalystSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Research analysts at Zacks Research increased their FY2025 EPS estimates for shares of Surmodics in a research note issued on Monday, November 25th. Zacks Research analyst D. Dey now expects that the company will post earnings per share of $0.14 for tNovember 27, 2024 | marketbeat.comPrincipal Financial Group Inc. Acquires Shares of 30,696 Surmodics, Inc. (NASDAQ:SRDX)Principal Financial Group Inc. acquired a new stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 30,696 shares of the company's stock, valued at approximately $November 24, 2024 | marketbeat.comSurModics Inc. Faces Legal Hurdles: Shareholder Lawsuits Threaten Merger and Financial StabilityNovember 22, 2024 | markets.businessinsider.comPhocas Financial Corp. Buys New Shares in Surmodics, Inc. (NASDAQ:SRDX)Phocas Financial Corp. bought a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 88,460 shares of the company's stock, valued at approximately $3,430,00November 19, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Now Covered by Analysts at StockNews.comStockNews.com assumed coverage on Surmodics in a report on Friday. They set a "hold" rating on the stock.November 15, 2024 | marketbeat.comFY2026 EPS Estimates for Surmodics Increased by AnalystSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Investment analysts at Barrington Research increased their FY2026 earnings per share (EPS) estimates for Surmodics in a report released on Thursday, November 7th. Barrington Research analyst M. Petusky now anticipates that the company will earn $0.89November 11, 2024 | marketbeat.comNisa Investment Advisors LLC Has $42,000 Stock Position in Surmodics, Inc. (NASDAQ:SRDX)Nisa Investment Advisors LLC lessened its holdings in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 98.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,093 shares of the company's stock after selling 67,336 shares durNovember 9, 2024 | marketbeat.comBarrington Research Lifts Earnings Estimates for SurmodicsSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Stock analysts at Barrington Research increased their FY2025 earnings per share (EPS) estimates for shares of Surmodics in a report issued on Thursday, November 7th. Barrington Research analyst M. Petusky now forecasts that the company will post earniNovember 8, 2024 | marketbeat.comSurmodics Inc. Reports Q4 and FY 2024 ResultsNovember 7, 2024 | markets.businessinsider.comHold Rating Maintained for SurModics Amid Acquisition UncertaintyNovember 7, 2024 | markets.businessinsider.comOlympiad Research LP Takes Position in Surmodics, Inc. (NASDAQ:SRDX)Olympiad Research LP bought a new stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 48,591 shares of the company's stock, valued at approximately $1,884,000. Surmodics aNovember 7, 2024 | marketbeat.comNeedham & Company LLC Reiterates Hold Rating for Surmodics (NASDAQ:SRDX)Needham & Company LLC reaffirmed a "hold" rating on shares of Surmodics in a research report on Thursday.November 7, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Stock Price Passes Above 200-Day Moving Average - Time to Sell?Surmodics (NASDAQ:SRDX) Share Price Crosses Above Two Hundred Day Moving Average - Here's What HappenedNovember 7, 2024 | marketbeat.comSurmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy SystemOctober 30, 2024 | businesswire.comSurmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.comStockNews.com started coverage on shares of Surmodics in a report on Wednesday. They issued a "hold" rating on the stock.October 30, 2024 | marketbeat.comMillennium Management LLC Trims Holdings in Surmodics, Inc. (NASDAQ:SRDX)Millennium Management LLC trimmed its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 86.8% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 76,997 shares of the company's stock after selling 506,030 shares during the period. Millennium ManagemOctober 15, 2024 | marketbeat.comSurmodics, Inc. Expected to Earn FY2025 Earnings of $0.13 Per Share (NASDAQ:SRDX)Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Research analysts at Zacks Research upped their FY2025 earnings per share (EPS) estimates for Surmodics in a research report issued on Wednesday, October 9th. Zacks Research analyst D. Dey now forecasts that the company will post earnings per share ofOctober 14, 2024 | marketbeat.comAQR Capital Management LLC Cuts Position in Surmodics, Inc. (NASDAQ:SRDX)AQR Capital Management LLC lessened its position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 53.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,228 shares of the company's stock afOctober 13, 2024 | marketbeat.com13,722 Shares in Surmodics, Inc. (NASDAQ:SRDX) Acquired by Algert Global LLCAlgert Global LLC acquired a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 13,722 shares of the company's stock, valued at approximately $577,000. Algert Global LLC owned about 0.10%October 7, 2024 | marketbeat.comWater Island Capital LLC Makes New $1.16 Million Investment in Surmodics, Inc. (NASDAQ:SRDX)Water Island Capital LLC acquired a new stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 27,592 shares of the company's stock, valued at approximately $1September 30, 2024 | marketbeat.comDisciplined Growth Investors Inc. MN Sells 78,609 Shares of Surmodics, Inc. (NASDAQ:SRDX)Disciplined Growth Investors Inc. MN lowered its holdings in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 11.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 580,566 shares of the company's stock afterSeptember 29, 2024 | marketbeat.comStockNews.com Begins Coverage on Surmodics (NASDAQ:SRDX)StockNews.com initiated coverage on Surmodics in a research note on Saturday. They issued a "hold" rating on the stock.September 28, 2024 | marketbeat.comSurmodics, Inc. (SRDX)September 24, 2024 | finance.yahoo.comSagefield Capital LP Invests $2.35 Million in Surmodics, Inc. (NASDAQ:SRDX)Sagefield Capital LP acquired a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 55,900 shares of the company's stock, valued at appSeptember 24, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Bought by Renaissance Technologies LLCRenaissance Technologies LLC boosted its holdings in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 5.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 606,538 shares of the company's stock aftSeptember 20, 2024 | marketbeat.comGardner Lewis Asset Management L P Buys Shares of 202,934 Surmodics, Inc. (NASDAQ:SRDX)Gardner Lewis Asset Management L P purchased a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 202,934 shares of the company's stock, valued at appSeptember 18, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Receives New Coverage from Analysts at StockNews.comStockNews.com initiated coverage on Surmodics in a report on Thursday. They issued a "hold" rating for the company.September 12, 2024 | marketbeat.comTrium Capital LLP Takes $1.41 Million Position in Surmodics, Inc. (NASDAQ:SRDX)Trium Capital LLP purchased a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 33,434 shares of the company's stock, valued at approximSeptember 9, 2024 | marketbeat.comWolverine Asset Management LLC Takes Position in Surmodics, Inc. (NASDAQ:SRDX)Wolverine Asset Management LLC bought a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 25,966 shares of the company's stock, valued at approximately $1,092,000. WSeptember 5, 2024 | marketbeat.comVersor Investments LP Purchases Shares of 64,770 Surmodics, Inc. (NASDAQ:SRDX)Versor Investments LP acquired a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 64,770 shares of the company's stock, valued at approximately $2September 2, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Short Interest UpdateSurmodics, Inc. (NASDAQ:SRDX - Get Free Report) saw a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 462,000 shares, a decrease of 36.9% from the July 31st total of 732,100 shares. Based on an average daily volume of 466,400 shares, the short-interest ratio is currently 1.0 days. Approximately 3.4% of the shares of the stock are sold short.August 28, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Acquired by Nisa Investment Advisors LLCNisa Investment Advisors LLC grew its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 4,722.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,429 shares of the company's stock after purchasingAugust 21, 2024 | marketbeat.comSurmodics, Inc. Expected to Earn FY2024 Earnings of ($0.47) Per Share (NASDAQ:SRDX)Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities researchers at Zacks Research lifted their FY2024 earnings per share estimates for shares of Surmodics in a research report issued on Wednesday, August 14th. Zacks Research analyst D. Dey now expects that the company will post earnings per shAugust 19, 2024 | marketbeat.comZacks Research Analysts Increase Earnings Estimates for Surmodics, Inc. (NASDAQ:SRDX)Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Research analysts at Zacks Research lifted their Q1 2026 earnings estimates for Surmodics in a report released on Wednesday, August 14th. Zacks Research analyst D. Dey now forecasts that the company will post earnings per share of $0.22 for the quarteAugust 16, 2024 | marketbeat.comHold Rating Maintained Amid SurModics Acquisition Delays and FTC ScrutinyAugust 15, 2024 | markets.businessinsider.comSurmodics (NASDAQ:SRDX) Sees Unusually-High Trading VolumeSurmodics (NASDAQ:SRDX) Sees Strong Trading VolumeAugust 12, 2024 | marketbeat.comSurModics Hold Rating Amidst Slowing Growth and Pending Acquisition UncertaintyAugust 6, 2024 | markets.businessinsider.comSurmodics (NASDAQ:SRDX) Given Hold Rating at Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Surmodics in a research note on Monday.August 5, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Forecasted to Post FY2026 Earnings of $0.87 Per ShareSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities researchers at Barrington Research reduced their FY2026 EPS estimates for Surmodics in a research report issued on Thursday, August 1st. Barrington Research analyst M. Petusky now expects that the company will post earnings of $0.87 per shareAugust 5, 2024 | marketbeat.comSRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q3 2024July 31, 2024 | investorplace.com Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol SRDX Media Mentions By Week SRDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRDX News Sentiment▼1.230.79▲Average Medical News Sentiment SRDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRDX Articles This Week▼32▲SRDX Articles Average Week Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Integra LifeSciences News Today AtriCure News Today Alphatec News Today Orthofix Medical News Today AngioDynamics News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Abbott Laboratories News Today Intuitive Surgical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRDX) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
